Gujarat Alkalies & Chemicals Ltd
Incorporated in 1973, Gujarat Alkalies and Chemicals Ltd is promoted by the Government of Gujarat, with promoter-group shareholding of 47.28% as of FY26.
The company operates manufacturing complexes at Vadodara and Dahej, Gujarat, and has 50+ years of operating history in chlor-alkali and allied chemicals.[1]
- Market Cap ₹ 5,049 Cr.
- Current Price ₹ 688
- High / Low ₹ 815 / 409
- Stock P/E 76.0
- Book Value ₹ 759
- Dividend Yield 2.31 %
- ROCE 1.69 %
- ROE 0.36 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.94 times its book value
- Company has been maintaining a healthy dividend payout of 427%
Cons
- Company has a low return on equity of -0.53% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Part of BSE Commodities BSE 1000
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,948 | 1,995 | 2,070 | 2,455 | 3,161 | 2,725 | 2,429 | 3,759 | 4,516 | 3,807 | 4,073 | 4,358 | 4,498 | |
| 1,674 | 1,660 | 1,621 | 1,668 | 2,046 | 2,147 | 2,071 | 2,772 | 3,402 | 3,671 | 3,712 | 3,953 | 3,988 | |
| Operating Profit | 274 | 335 | 450 | 787 | 1,115 | 578 | 358 | 987 | 1,115 | 136 | 360 | 405 | 510 |
| OPM % | 14% | 17% | 22% | 32% | 35% | 21% | 15% | 26% | 25% | 4% | 9% | 9% | 11% |
| 49 | 45 | 56 | 106 | 61 | 90 | 67 | 46 | 42 | 90 | 92 | 117 | 116 | |
| Interest | 9 | 10 | 13 | 15 | 21 | 14 | 15 | 6 | 19 | 45 | 51 | 63 | 66 |
| Depreciation | 98 | 107 | 111 | 127 | 140 | 162 | 174 | 198 | 276 | 377 | 392 | 414 | 416 |
| Profit before tax | 215 | 263 | 382 | 750 | 1,015 | 492 | 236 | 829 | 861 | -196 | 10 | 44 | 144 |
| Tax % | -6% | 16% | 19% | 29% | 32% | 32% | 29% | 32% | 33% | -32% | -63% | 53% | |
| 228 | 220 | 308 | 535 | 690 | 333 | 167 | 562 | 576 | -132 | 16 | 21 | 66 | |
| EPS in Rs | 31.03 | 29.94 | 41.95 | 72.85 | 93.91 | 45.32 | 22.72 | 76.53 | 78.39 | -18.01 | 2.15 | 2.84 | 9.05 |
| Dividend Payout % | 14% | 15% | 12% | 9% | 9% | 18% | 35% | 13% | 30% | -77% | 733% | 624% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 12% |
| 3 Years: | -1% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -21% |
| 5 Years: | -34% |
| 3 Years: | -67% |
| TTM: | 38% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 7% |
| 3 Years: | 0% |
| 1 Year: | 7% |
| Return on Equity | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 3% |
| 3 Years: | -1% |
| Last Year: | 0% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 73 | 73 | 73 | 73 | 73 | 73 | 73 | 73 | 73 | 73 | 73 | 73 |
| Reserves | 2,063 | 2,855 | 3,283 | 3,749 | 4,223 | 4,524 | 5,304 | 5,831 | 6,237 | 6,278 | 5,953 | 5,497 |
| 158 | 295 | 353 | 291 | 247 | 205 | 498 | 594 | 597 | 544 | 561 | 575 | |
| 693 | 671 | 726 | 859 | 988 | 1,090 | 1,282 | 1,484 | 1,599 | 1,404 | 1,756 | 1,766 | |
| Total Liabilities | 2,988 | 3,895 | 4,437 | 4,972 | 5,532 | 5,893 | 7,157 | 7,983 | 8,506 | 8,299 | 8,343 | 7,913 |
| 1,656 | 1,821 | 2,073 | 2,104 | 2,300 | 2,610 | 2,587 | 2,702 | 4,250 | 4,617 | 4,584 | 4,343 | |
| CWIP | 67 | 83 | 151 | 252 | 307 | 445 | 1,109 | 1,787 | 544 | 95 | 79 | 122 |
| Investments | 193 | 855 | 1,017 | 1,147 | 1,066 | 1,244 | 2,095 | 2,115 | 2,002 | 2,369 | 2,332 | 2,013 |
| 1,072 | 1,136 | 1,195 | 1,469 | 1,858 | 1,594 | 1,366 | 1,379 | 1,710 | 1,218 | 1,348 | 1,434 | |
| Total Assets | 2,988 | 3,895 | 4,437 | 4,972 | 5,532 | 5,893 | 7,157 | 7,983 | 8,506 | 8,299 | 8,343 | 7,913 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 295 | 201 | 503 | 515 | 838 | 630 | 421 | 735 | 960 | 67 | 381 | 406 | |
| -212 | -352 | -468 | -395 | -581 | -634 | -334 | -804 | -662 | -90 | -264 | -228 | |
| -88 | 84 | 13 | -116 | -136 | -146 | 226 | 12 | -140 | -277 | -145 | -150 | |
| Net Cash Flow | -5 | -67 | 49 | 3 | 122 | -150 | 313 | -58 | 158 | -301 | -28 | 28 |
| Free Cash Flow | 95 | -80 | 64 | 231 | 451 | 56 | -370 | -173 | 277 | -164 | 59 | 148 |
| CFO/OP | 128% | 75% | 132% | 83% | 98% | 120% | 132% | 106% | 103% | 82% | 87% | 95% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 57 | 60 | 58 | 60 | 56 | 50 | 43 | 29 | 23 | 17 | 24 | 34 |
| Inventory Days | 96 | 99 | 94 | 147 | 99 | 92 | 88 | 101 | 111 | 93 | 110 | 102 |
| Days Payable | 119 | 99 | 125 | 154 | 134 | 126 | 111 | 101 | 119 | 86 | 115 | 111 |
| Cash Conversion Cycle | 34 | 60 | 27 | 53 | 22 | 17 | 21 | 29 | 15 | 25 | 19 | 25 |
| Working Capital Days | 47 | 89 | 81 | 98 | 96 | 107 | 10 | 4 | 5 | -1 | -3 | 1 |
| ROCE % | 10% | 10% | 11% | 18% | 24% | 11% | 5% | 14% | 13% | -2% | 1% | 2% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Caustic Soda Capacity Utilization % |
|
|||||||||
| Caustic Soda Installed Capacity MT |
||||||||||
| Caustic Soda Lye Production Volume MT |
||||||||||
| Caustic Soda Market Share % |
||||||||||
| Chloromethanes Production Volume MT |
||||||||||
| Hydrogen Peroxide Production Volume MT |
||||||||||
| Phosphoric Acid (85%) Production Volume MT |
||||||||||
| Renewable Energy Installed Capacity MW |
||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
15h - Q1 FY27 revenue rose 14% to Rs1,224.84 crore; EBITDA up 83%; Rs55 crore HCL unit approved.
-
Disclosure Of Information Under Regulation 30(3) Of SEBI (Listing
Obligations And Disclosure Requirements) Regulations, 2015 - In Principle Approval For Putting Up One More HCL Synthesis Unit At Dahej.
16h - Board approves in-principle one more HCL synthesis unit at Dahej, with approximate project cost of Rs.55l crores.
-
Outcome Of The Board Meeting Held On 23Rd July, 2026 For Approval Of Standalone & Consolidated Un-Audited (Provisional) Financial Results For The Quarter Ended On 30Th June, 2026 And Other Matters.
17h - Q1 FY2027 results approved; board cleared one HCL synthesis unit at Dahej for about Rs.55 crore.
-
Board Meeting Outcome for Outcome Of The Board Meeting Held On 23Rd July, 2026 For Approval Of Standalone & Consolidated Un-Audited (Provisional) Financial Results For The Quarter Ended On 30Th June, 2026 And Other Matters.
17h - Q1 FY27 results approved; board cleared one HCL synthesis unit at Dahej, costing about Rs.55 crore.
- Closure of Trading Window 13 Jul
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from nse
Concalls
-
Jul 2026TranscriptAI SummaryPPT
-
Feb 2025TranscriptAI SummaryPPT
-
Jun 2024TranscriptAI SummaryPPT
-
Mar 2024TranscriptAI SummaryPPT
-
Dec 2023TranscriptAI SummaryPPT
-
Nov 2023TranscriptAI SummaryPPT
-
Jun 2023TranscriptAI SummaryPPT
-
Feb 2023TranscriptAI SummaryPPT
-
Nov 2022TranscriptAI SummaryPPT
-
Aug 2022TranscriptAI SummaryPPT
-
Jun 2022TranscriptAI SummaryPPT
-
Feb 2022TranscriptAI SummaryPPT
-
Nov 2021TranscriptAI SummaryPPT
-
Aug 2021TranscriptAI SummaryPPT
-
May 2021TranscriptAI SummaryPPT
-
Feb 2021TranscriptAI SummaryPPT
-
Dec 2020TranscriptAI SummaryPPT
-
Aug 2020TranscriptAI SummaryPPT
-
Jun 2020TranscriptAI SummaryPPT
-
Feb 2020TranscriptAI SummaryPPT
-
Nov 2019TranscriptAI SummaryPPT
-
Jun 2019TranscriptAI SummaryPPT
-
Mar 2017TranscriptAI SummaryPPT
-
May 2016TranscriptPPT
Product Offerings
The company has over 36 products in its portfolio, including Caustic Soda lye, flakes, and prills, Chloromethanes, Liquid Chlorine, Hydrochloric Acid, Hydrogen Peroxide, Anhydrous Aluminum Chloride, Caustic Potash lye and flakes, Potassium Carbonate granules and powder, Aluminium Chloride, Phosphoric Acid, etc. These products are utilized across industries such as textiles, pulp and paper, alumina, soaps& detergents, and water treatment, etc. [1]